TrialScientific reports2023

Gene expression alterations predict the pathological complete response in triple-negative breast cancer exploratory analysis of the NACATRINE trial.

Ana Julia Aguiar Freitas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.